These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 2742818)
1. Platelet receptor recognition domains on the alpha chain of human fibrinogen: structure-function analysis. Hawiger J; Kloczewiak M; Bednarek MA; Timmons S Biochemistry; 1989 Apr; 28(7):2909-14. PubMed ID: 2742818 [TBL] [Abstract][Full Text] [Related]
2. Antiplatelet "hybrid" peptides analogous to receptor recognition domains on gamma and alpha chains of human fibrinogen. Timmons S; Bednarek MA; Kloczewiak M; Hawiger J Biochemistry; 1989 Apr; 28(7):2919-23. PubMed ID: 2742820 [TBL] [Abstract][Full Text] [Related]
3. Platelet receptor recognition domain on the gamma chain of human fibrinogen and its synthetic peptide analogues. Kloczewiak M; Timmons S; Bednarek MA; Sakon M; Hawiger J Biochemistry; 1989 Apr; 28(7):2915-9. PubMed ID: 2742819 [TBL] [Abstract][Full Text] [Related]
4. Platelet receptor recognition site on human fibrinogen. Synthesis and structure-function relationship of peptides corresponding to the carboxy-terminal segment of the gamma chain. Kloczewiak M; Timmons S; Lukas TJ; Hawiger J Biochemistry; 1984 Apr; 23(8):1767-74. PubMed ID: 6326808 [TBL] [Abstract][Full Text] [Related]
5. Effects of hybrid peptide analogs to receptor recognition domains on alpha- and gamma-chains of human fibrinogen on fibrinogen binding to platelets. Mohri H; Ohkubo T Thromb Haemost; 1993 May; 69(5):490-5. PubMed ID: 8322271 [TBL] [Abstract][Full Text] [Related]
6. The role of the RGD peptides and the gamma chain peptide of fibrinogen on fibrinogen binding to activated platelets. Mohri H; Ohkubo T Peptides; 1993; 14(2):353-7. PubMed ID: 8483813 [TBL] [Abstract][Full Text] [Related]
7. Localization of the cross-linking sites of RGD and KQAGDV peptides to the isolated fibrinogen receptor, the human platelet integrin glycoprotein IIb/IIIa. Influence of peptide length. Calvete JJ; Schäfer W; Mann K; Henschen A; González-Rodríguez J Eur J Biochem; 1992 Jun; 206(3):759-65. PubMed ID: 1376688 [TBL] [Abstract][Full Text] [Related]
8. Beta 3 integrin derived peptide 217-230 inhibits fibrinogen binding and platelet aggregation: significance of RGD sequences and fibrinogen A alpha-chain. Lasz EC; McLane MA; Trybulec M; Kowalska MA; Khan S; Budzynski AZ; Niewiarowski S Biochem Biophys Res Commun; 1993 Jan; 190(1):118-24. PubMed ID: 8422238 [TBL] [Abstract][Full Text] [Related]
9. Amino acid sequences in fibrinogen mediating its interaction with its platelet receptor, GPIIbIIIa. Andrieux A; Hudry-Clergeon G; Ryckewaert JJ; Chapel A; Ginsberg MH; Plow EF; Marguerie G J Biol Chem; 1989 Jun; 264(16):9258-65. PubMed ID: 2722830 [TBL] [Abstract][Full Text] [Related]
10. A monoclonal antibody against the platelet fibrinogen receptor contains a sequence that mimics a receptor recognition domain in fibrinogen. Taub R; Gould RJ; Garsky VM; Ciccarone TM; Hoxie J; Friedman PA; Shattil SJ J Biol Chem; 1989 Jan; 264(1):259-65. PubMed ID: 2909518 [TBL] [Abstract][Full Text] [Related]
12. Recognition site for the platelet receptor is present on the 15-residue carboxy-terminal fragment of the gamma chain of human fibrinogen and is not involved in the fibrin polymerization reaction. Kloczewiak M; Timmons S; Hawiger J Thromb Res; 1983 Jan; 29(2):249-55. PubMed ID: 6302942 [TBL] [Abstract][Full Text] [Related]
13. The integrin alpha IIb beta 3 contains distinct and interacting binding sites for snake-venom RGD (Arg-Gly-Asp) proteins. Evidence that the receptor-binding characteristics of snake-venom RGD proteins are related to the amino acid environment flanking the sequence RGD. Rahman S; Lu X; Kakkar VV; Authi KS Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):223-32. PubMed ID: 7492316 [TBL] [Abstract][Full Text] [Related]
14. A synthetic peptide with anti-platelet activity derived from a CDR of an anti-GPIIb-IIIa antibody. Jarrin A; Andrieux A; Chapel A; Buchou T; Marguerie G FEBS Lett; 1994 Nov; 354(2):169-72. PubMed ID: 7957919 [TBL] [Abstract][Full Text] [Related]
15. Characterization of the interaction between the Staphylococcus aureus clumping factor (ClfA) and fibrinogen. McDevitt D; Nanavaty T; House-Pompeo K; Bell E; Turner N; McIntire L; Foster T; Höök M Eur J Biochem; 1997 Jul; 247(1):416-24. PubMed ID: 9249055 [TBL] [Abstract][Full Text] [Related]
16. Trigramin: primary structure and its inhibition of von Willebrand factor binding to glycoprotein IIb/IIIa complex on human platelets. Huang TF; Holt JC; Kirby EP; Niewiarowski S Biochemistry; 1989 Jan; 28(2):661-6. PubMed ID: 2653425 [TBL] [Abstract][Full Text] [Related]
17. Triflavin, an antiplatelet Arg-Gly-Asp-containing peptide, is a specific antagonist of platelet membrane glycoprotein IIb-IIIa complex. Huang TF; Sheu JR; Teng CM; Chen SW; Liu CS J Biochem; 1991 Feb; 109(2):328-34. PubMed ID: 1864844 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of platelet function with synthetic peptides designed to be high-affinity antagonists of fibrinogen binding to platelets. Ruggeri ZM; Houghten RA; Russell SR; Zimmerman TS Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5708-12. PubMed ID: 3016716 [TBL] [Abstract][Full Text] [Related]